Norihiko Goto

6PUBLICATIONS
38CO-AUTHORS
Medical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)Food properties (incl. characteristics and health benefits)Solid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 16, 2026
Unanticipated global emergence and evolution of Pneumocystis jirovecii mutations and resistance driven by a human-targeted drug.

|Mar 28, 2022
Two-year outcomes of low-exposure extended-release tacrolimus and mycophenolate mofetil regimen in de novo kidney transplantation: A multi-center randomized controlled trial.

Yuji Hidaka, Norihiko Goto, Shigeyoshi Yamanaga

|Nov 08, 2021
Cholecalciferol Supplementation Attenuates Bone Loss in Incident Kidney Transplant Recipients: A Prespecified Secondary Endpoint Analysis of a Randomized Controlled Trial.

Makoto Tsujita, Yohei Doi, Yoshitsugu Obi

|Aug 14, 2021
Oral/oesophageal candidiasis is a risk factor for severe infection after kidney transplantation.

Tetsuya Abe, Kenta Futamura, Norihiko Goto

|Feb 10, 2021
The effect of cholecalciferol supplementation on allograft function in incident kidney transplant recipients: A randomized controlled study.

Yohei Doi, Makoto Tsujita, Takayuki Hamano

Pageof 1

Frequent Collaborators

3 joint publications

Makoto Tsujita

3 joint publications

Manabu Okada

2 joint publications

Yohei Doi

2 joint publications

Takayuki Hamano